Larasati Arrum Kusumawardani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Larasati Arrum Kusumawardani has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Adelia Nathifa Rachma Nur Setiati
Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
1 shared publication- Angga Iw Effendi
Bantur Community Health Centre, Malang Regency Government, Malang, Indonesia
1 shared publication Annisa Puspasari
Faculty of Pharmacy Universitas Indonesia
1 shared publication- Ayuk Lawuningtyas Hariadini
Department of Pharmacy, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
1 shared publication Azizah Wati
Faculty of Pharmacy Universitas Indonesia
1 shared publicationDarisa Naurahhanan
Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia
1 shared publication
Latest Publications
- Open Access
- 31 July 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (07) , 954-961
The quantitative evaluation of antibiotic utilization in community health centers during the COVID-19 pandemic: a cross-sectional multicenter study
Introduction: Uncertainty and rapid changes in treatment guidelines are influencing factors for medication use during the COVID-19 pandemic. Therefore, this study aimed to evaluate antibiotic utilization in Community Health Centers (CHCs) between 2020 and 2021. Methodology: Prescription data from adult outpatient visits (≥ 18 years) receiving prescription services at 35 CHCs in South Jakarta, Malang regency, and Bengkulu city, comprising 796,598 prescriptions, were examined using the ATC/DDD methodology and DU90% analysis. These regions were purposively selected to represent three distinct healthcare archetypes, namely metropolitan (South Jakarta), rural-urban continuum (Malang Regency), and regional cities outside Java (Bengkulu City). Wilcoxon signed-rank and Chi-square tests were used to determine statistical differences between years. Results: The proportion of adult patient visits receiving a minimum of one antibiotic prescription decreased by 1.56% in 2021 (p < 0.001). Malang Regency recorded the highest rates, decreasing by 2.24% in 2021. Furthermore, the highest DDD values for all antibiotics each year were recorded in South Jakarta, except for Cefadroxil, which peaked in Malang regency. Six antibiotics were constituted in the DU90% segment, with Amoxicillin accounting for over 50% of prescriptions and reaching 425 DDD/1000 patient visits/year in South Jakarta in 2020. In 2021, Azithromycin prescriptions increased significantly by 7.51%, as shown by a p of 0.0161. The average prescribing rate (14.57%) remained below the WHO optimal indicator (< 30%). Conclusions: Antibiotic use in CHCs declined during the pandemic, but there was a significant increase in Azithromycin prescriptions.
- 31 July 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (07) , 954-961
Open AccessThe quantitative evaluation of antibiotic utilization in community health centers during the COVID-19 pandemic: a cross-sectional multicenter study
Introduction: Uncertainty and rapid changes in treatment guidelines are influencing factors for medication use during the COVID-19 pandemic. Therefore, this study aimed to evaluate antibiotic utilization in Community Health Centers (CHCs) between 2020 and 2021. Methodology: Prescription data from adult outpatient visits (≥ 18 years) receiving prescription services at 35 CHCs in South Jakarta, Malang regency, and Bengkulu city, comprising 796,598 prescriptions, were examined using the ATC/DDD methodology and DU90% analysis. These regions were purposively selected to represent three distinct healthcare archetypes, namely metropolitan (South Jakarta), rural-urban continuum (Malang Regency), and regional cities outside Java (Bengkulu City). Wilcoxon signed-rank and Chi-square tests were used to determine statistical differences between years. Results: The proportion of adult patient visits receiving a minimum of one antibiotic prescription decreased by 1.56% in 2021 (p < 0.001). Malang Regency recorded the highest rates, decreasing by 2.24% in 2021. Furthermore, the highest DDD values for all antibiotics each year were recorded in South Jakarta, except for Cefadroxil, which peaked in Malang regency. Six antibiotics were constituted in the DU90% segment, with Amoxicillin accounting for over 50% of prescriptions and reaching 425 DDD/1000 patient visits/year in South Jakarta in 2020. In 2021, Azithromycin prescriptions increased significantly by 7.51%, as shown by a p of 0.0161. The average prescribing rate (14.57%) remained below the WHO optimal indicator (< 30%). Conclusions: Antibiotic use in CHCs declined during the pandemic, but there was a significant increase in Azithromycin prescriptions.
- Open Access
- 20 March 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
The urge for specific standards of telepharmacy services: Lessons learned from qualitative study in Indonesian community pharmacies
Objective: Like many low- and middle-income countries, Indonesia lacks specific standards for telepharmacy practices, which requires adherence to traditional pharmacy guidelines to evaluate the services. This study aims to explore the disparities between the implementation of telepharmacy services in community pharmacies and the established Indonesian pharmaceutical service standards. Methods: This qualitative study was conducted in seven community pharmacies in Depok, an urban area near Jakarta. Data were collected in 2023 using triangulation methods: semi-structured interviews, direct observations, and simulated patient interactions. Verbatim transcriptions and thematic analysis were performed using NVivo ® 12 to analyse the findings. Results: Four identified themes were the structures, daily practices, challenges, and enablers of telepharmacy services. The scope of telepharmacy services consisted of dispensing medicines, patient education, and providing drug information through mobile applications by pharmacy electronic system organisers (PSEF) or social media platforms. Challenges in daily practice revealed gaps in traditional pharmaceutical service guidelines, including systems interoperability, effective communication among pharmacists-physician-patients, and the need for standards specific to digital pharmaceutical services. Common problems in telepharmacy were uncertain medicine availability, unclear e-prescription validity, limited pharmacist-physician collaboration, and impeded patient education, particularly in services provided through PSEF applications. On the other hand, the availability of digital technologies was seen as beneficial, highlighting the necessity for predefined standardised facilities to ensure the quality of telepharmacy services. Conclusion: While traditional pharmaceutical service standards can be applied to evaluate telepharmacy practices, specific challenges must be explicitly addressed within a dedicated telepharmacy standard to ensure patient safety and service quality.
- 20 March 2025
- Published by SAGE Publications in Digital Health
- Vol. 11
Open AccessThe urge for specific standards of telepharmacy services: Lessons learned from qualitative study in Indonesian community pharmacies
Objective: Like many low- and middle-income countries, Indonesia lacks specific standards for telepharmacy practices, which requires adherence to traditional pharmacy guidelines to evaluate the services. This study aims to explore the disparities between the implementation of telepharmacy services in community pharmacies and the established Indonesian pharmaceutical service standards. Methods: This qualitative study was conducted in seven community pharmacies in Depok, an urban area near Jakarta. Data were collected in 2023 using triangulation methods: semi-structured interviews, direct observations, and simulated patient interactions. Verbatim transcriptions and thematic analysis were performed using NVivo ® 12 to analyse the findings. Results: Four identified themes were the structures, daily practices, challenges, and enablers of telepharmacy services. The scope of telepharmacy services consisted of dispensing medicines, patient education, and providing drug information through mobile applications by pharmacy electronic system organisers (PSEF) or social media platforms. Challenges in daily practice revealed gaps in traditional pharmaceutical service guidelines, including systems interoperability, effective communication among pharmacists-physician-patients, and the need for standards specific to digital pharmaceutical services. Common problems in telepharmacy were uncertain medicine availability, unclear e-prescription validity, limited pharmacist-physician collaboration, and impeded patient education, particularly in services provided through PSEF applications. On the other hand, the availability of digital technologies was seen as beneficial, highlighting the necessity for predefined standardised facilities to ensure the quality of telepharmacy services. Conclusion: While traditional pharmaceutical service standards can be applied to evaluate telepharmacy practices, specific challenges must be explicitly addressed within a dedicated telepharmacy standard to ensure patient safety and service quality.
- Open Access
- 1 February 2025
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 18, 59-69
Assessment of Potentially Nephrotoxic Drug Prescriptions in Chronic Kidney Disease Outpatients at a Hospital in Indonesia
Background: Nephrotoxic drugs can worsen the kidney function of patients with chronic kidney disease (CKD). There is still a limited amount of research investigating nephrotoxic drugs in Indonesia. This study aims to analyze the prevalence of potentially nephrotoxic drugs (PND) prescriptions and the association of patients’ characteristics with PND prescribing. Methods: This cross-sectional study employed retrospective data from Universitas Indonesia Hospital (RSUI), focusing on CKD outpatients treated between January 2019 and December 2022. CKD patients over the age of 18 were included, with exclusions for those suspected of having CKD, those with a history of kidney transplants, or missing critical data. The study outcome was the prevalence of patients prescribed PND, determined using reliable references to assess potential nephrotoxicity. Furthermore, compliance with clinical guidelines was evaluated at the individual drug level, with each PND within a prescription treated as a separate case. Descriptive analyses were carried out to determine prevalence, which were presented as percentages. Logistic regression analysis was performed to examine the association between patient characteristics and the prescription of PND. Results: In total, 248 patients were evaluated. The findings revealed that 177 out of 248 patients (71.4%) were prescribed at least one PND. The categories of these drugs included antihypertensives (50.9%), antigout medications (17.8%), antiplatelets (10.5%), antibiotics (9.8%), NSAIDs (5.8%), and antiulcer agents (5.2%). Of 275 cases of PND prescriptions, 220 (80.0%) complied to treatment guidelines, while 55 (20.0%) did not. Logistic regression analysis indicated that patients taking more than four additional medications were more likely to be prescribed PNDs than those on fewer medications (aOR 2.454, 95% CI 1.399– 4.305). Conclusion: Although non-compliance cases are relatively low, PNDs are frequently prescribed to CKD patients, with the risk rising as the number of comedications increases. Measures are needed to ensure guideline compliance, including accurate dosage assessments and outcome monitoring.
- 1 February 2025
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 18, 59-69
Open AccessAssessment of Potentially Nephrotoxic Drug Prescriptions in Chronic Kidney Disease Outpatients at a Hospital in Indonesia
Background: Nephrotoxic drugs can worsen the kidney function of patients with chronic kidney disease (CKD). There is still a limited amount of research investigating nephrotoxic drugs in Indonesia. This study aims to analyze the prevalence of potentially nephrotoxic drugs (PND) prescriptions and the association of patients’ characteristics with PND prescribing. Methods: This cross-sectional study employed retrospective data from Universitas Indonesia Hospital (RSUI), focusing on CKD outpatients treated between January 2019 and December 2022. CKD patients over the age of 18 were included, with exclusions for those suspected of having CKD, those with a history of kidney transplants, or missing critical data. The study outcome was the prevalence of patients prescribed PND, determined using reliable references to assess potential nephrotoxicity. Furthermore, compliance with clinical guidelines was evaluated at the individual drug level, with each PND within a prescription treated as a separate case. Descriptive analyses were carried out to determine prevalence, which were presented as percentages. Logistic regression analysis was performed to examine the association between patient characteristics and the prescription of PND. Results: In total, 248 patients were evaluated. The findings revealed that 177 out of 248 patients (71.4%) were prescribed at least one PND. The categories of these drugs included antihypertensives (50.9%), antigout medications (17.8%), antiplatelets (10.5%), antibiotics (9.8%), NSAIDs (5.8%), and antiulcer agents (5.2%). Of 275 cases of PND prescriptions, 220 (80.0%) complied to treatment guidelines, while 55 (20.0%) did not. Logistic regression analysis indicated that patients taking more than four additional medications were more likely to be prescribed PNDs than those on fewer medications (aOR 2.454, 95% CI 1.399– 4.305). Conclusion: Although non-compliance cases are relatively low, PNDs are frequently prescribed to CKD patients, with the risk rising as the number of comedications increases. Measures are needed to ensure guideline compliance, including accurate dosage assessments and outcome monitoring.
- Open Access
- 29 July 2024
- Published by Ikatan Apoteker Indonesia in Jfionline
- Vol. 16 (2) , 126-135
Pengembangan Kuesioner PTFKP untuk Mengevaluasi Pelayanan Telefarmasi Berupa Kepuasan Pasien Berdasarkan Mutu Pelayanan WHO
Telefarmasi merupakan salah satu pelayanan kefarmasian yang saat ini berkembang dan banyak dimanfaatkan masyarakat ataupun fasilitas kesehatan di era digital. Untuk menjamin kualitas, pelayanan telefarmasi sebaiknya dapat memenuhi dimensi mutu pelayanan kesehatan. Menurut WHO, dimensi mutu pelayanan kesehatan terdiri dari efektif, efisien, mudah diakses, berpusat pada pasien, adil, dan aman. Namun, instrumen yang dapat digunakan untuk menilai mutu pelayananan telefarmasi masih sangat terbatas. Penelitian ini bertujuan untuk mengembangkan kuesioner yang dapat digunakan untuk mengevaluasi mutu pelayanan telefarmasi, terutama dari perspektif kepuasan pasien. Pengembangan kuesioner PTFKP (Pelayanan Telefarmasi berdasarkan Kepuasan Pasien) dilakukan berdasarkan enam dimensi mutu pelayanan WHO. Validasi isi dilakukan dua tahap oleh tiga orang tim ahli berupa akademisi dan apoteker komunitas. Validasi muka, konstruk dan uji reabilitas dilakukan pada 30 responden yang memenuhi kriteria berupa usia >18 tahun dan menggunakan pelayanan telefarmasi dalam 2 tahun terakhir. Uji validitas isi menunjukkan nilai I-CVI 0,71 (putaran pertama) dan I-CVI 1,00 (putaran kedua). Pada validasi konstruk dengan metode CITC (corrected item-total correlation) tahap 1, terdapat 10 pertanyaan yang memiliki nilai r yang belum memenuhi persyaratan. Setelah dilakukan revisi, nilai r setiap pertanyaan memenuhi kriteria dengan rentang r= 0,378–0,857 (rtabel= 0,361). Uji reabilitas dengan metode konsistensi interal menunjukkan nilai Cronbach’s alpha=0,805-0,900 pada setiap bagian dimensi mutu pelayanan. Jumlah pertanyaan yang valid dan reliabel berjumlah 5 untuk tiap dimensi efektif, efisien, berpusat pada pasien, dan aman, serta berjumlah 4 untuk tiap dimensi aksesibilitas dan adil. Kuesioner memenuhi persyaratan validitas dan rebilitas untuk digunakan dalam evaluasi mutu pelayanan telefarmasi berdasarkan kepuasan pasien.
- 29 July 2024
- Published by Ikatan Apoteker Indonesia in Jfionline
- Vol. 16 (2) , 126-135
Open AccessPengembangan Kuesioner PTFKP untuk Mengevaluasi Pelayanan Telefarmasi Berupa Kepuasan Pasien Berdasarkan Mutu Pelayanan WHO
Telefarmasi merupakan salah satu pelayanan kefarmasian yang saat ini berkembang dan banyak dimanfaatkan masyarakat ataupun fasilitas kesehatan di era digital. Untuk menjamin kualitas, pelayanan telefarmasi sebaiknya dapat memenuhi dimensi mutu pelayanan kesehatan. Menurut WHO, dimensi mutu pelayanan kesehatan terdiri dari efektif, efisien, mudah diakses, berpusat pada pasien, adil, dan aman. Namun, instrumen yang dapat digunakan untuk menilai mutu pelayananan telefarmasi masih sangat terbatas. Penelitian ini bertujuan untuk mengembangkan kuesioner yang dapat digunakan untuk mengevaluasi mutu pelayanan telefarmasi, terutama dari perspektif kepuasan pasien. Pengembangan kuesioner PTFKP (Pelayanan Telefarmasi berdasarkan Kepuasan Pasien) dilakukan berdasarkan enam dimensi mutu pelayanan WHO. Validasi isi dilakukan dua tahap oleh tiga orang tim ahli berupa akademisi dan apoteker komunitas. Validasi muka, konstruk dan uji reabilitas dilakukan pada 30 responden yang memenuhi kriteria berupa usia >18 tahun dan menggunakan pelayanan telefarmasi dalam 2 tahun terakhir. Uji validitas isi menunjukkan nilai I-CVI 0,71 (putaran pertama) dan I-CVI 1,00 (putaran kedua). Pada validasi konstruk dengan metode CITC (corrected item-total correlation) tahap 1, terdapat 10 pertanyaan yang memiliki nilai r yang belum memenuhi persyaratan. Setelah dilakukan revisi, nilai r setiap pertanyaan memenuhi kriteria dengan rentang r= 0,378–0,857 (rtabel= 0,361). Uji reabilitas dengan metode konsistensi interal menunjukkan nilai Cronbach’s alpha=0,805-0,900 pada setiap bagian dimensi mutu pelayanan. Jumlah pertanyaan yang valid dan reliabel berjumlah 5 untuk tiap dimensi efektif, efisien, berpusat pada pasien, dan aman, serta berjumlah 4 untuk tiap dimensi aksesibilitas dan adil. Kuesioner memenuhi persyaratan validitas dan rebilitas untuk digunakan dalam evaluasi mutu pelayanan telefarmasi berdasarkan kepuasan pasien.
- Open Access
- 1 April 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (2) , 134-139
Analysis of drug-related problems in ischemic stroke in-patients in one Indonesian district hospital
Background: Ischemic stroke is one of the leading causes of death in Indonesia. Appropriate management, including the identification of drug-related problems (DRPs), is needed to prevent disability and death. Objective: This study aimed to analyse DRPs as defined by the Pharmaceutical Care Network Europe (PCNE). Method: This was a cross-sectional research using the medical records of in-patients with ischemic stroke aged >18 years. Result: Out of the 115 patients examined, 51.3% were male, and the mean age was 57.85 + 10.539 years. Exactly 204 cases of DRPs and 175 causes appeared in 101 patients. A total of 58 patients experienced one-to-two problems, and 43 patients experienced more than two problems. The problems domain consists of therapeutic effectiveness (P1, 133(65.2%)), adverse effects (P2, 67(32, 84%)), and medical expenses (P3, 4(1, 96%)). The DRPs mostly involved antihypertension and antiplatelet. The most common cause was a new indication for treatment (C1.9, 51(29.14%)) and drug interactions (C8.1, 48(27.43%)). Multivariate analysis of patient characteristics showed that patients taking more than eight medications were more likely to experience more than two DRPs than those on one-to-four medications (OR 5.593; 95%, CI 1.015-30.812). Conclusion: Most patients experienced one-to-two DRPs with the highest being a potentially suboptimal treatment. Clinical pharmacists are expected to monitor therapy, especially in polypharmacy patients.
- 1 April 2024
- Published by International Pharmaceutical Federation (FIP) in Pharmacy Education
- Vol. 24 (2) , 134-139
Open AccessAnalysis of drug-related problems in ischemic stroke in-patients in one Indonesian district hospital
Background: Ischemic stroke is one of the leading causes of death in Indonesia. Appropriate management, including the identification of drug-related problems (DRPs), is needed to prevent disability and death. Objective: This study aimed to analyse DRPs as defined by the Pharmaceutical Care Network Europe (PCNE). Method: This was a cross-sectional research using the medical records of in-patients with ischemic stroke aged >18 years. Result: Out of the 115 patients examined, 51.3% were male, and the mean age was 57.85 + 10.539 years. Exactly 204 cases of DRPs and 175 causes appeared in 101 patients. A total of 58 patients experienced one-to-two problems, and 43 patients experienced more than two problems. The problems domain consists of therapeutic effectiveness (P1, 133(65.2%)), adverse effects (P2, 67(32, 84%)), and medical expenses (P3, 4(1, 96%)). The DRPs mostly involved antihypertension and antiplatelet. The most common cause was a new indication for treatment (C1.9, 51(29.14%)) and drug interactions (C8.1, 48(27.43%)). Multivariate analysis of patient characteristics showed that patients taking more than eight medications were more likely to experience more than two DRPs than those on one-to-four medications (OR 5.593; 95%, CI 1.015-30.812). Conclusion: Most patients experienced one-to-two DRPs with the highest being a potentially suboptimal treatment. Clinical pharmacists are expected to monitor therapy, especially in polypharmacy patients.